ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

analysis

Top Analyst Upgrades and Downgrades: CenturyLink, Gold Fields, Papa John’s, Priceline, SolarCity, Tesla, Unisys and More

Despite two days of pre-Brexit gains, stocks were indicated marginally higher again on Wednesday morning. While the reason seems to be different each and every time, investors have found the ...
Read Full Story »
happy couple

Merrill Lynch Has 3 Top BioPharma Picks to Win From the Aging of America

When investors hear the term "The Silver Economy," some may think of the metal silver. Other investors think of this as the aging trends happening in the world. There are now, ...
Read Full Story »
buy button

Massive Biotech Insider Buy Highlights Volatile Trading Week: Acadia, Conn’s, William Lyon, Summit Midstream and More

In a week that was eerily reminiscent of the first six weeks of 2016, the market took investors on a crazy ride that finally came to an end on Friday. Triple-digit ...
Read Full Story »
biotech word cloud

Top 6 Biopharma Movers of the Past Week

Over the past week, a few biotech companies made impressive runs. These moves were the result of clinical trial results, U.S. Food and Drug Administration (FDA) decisions and more. The ...
Read Full Story »
FDA_logo

Acadia Posts Big Win With FDA Approval

Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) saw its shares on the rise again this week following an incredibly positive U.S. Food and Drug Administration’s (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) vote. ...
Read Full Story »
Female patient on gurney

Why Merrill Lynch Sees Acadia Rising Another 60%

Shares of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) surged early on Monday morning. This company is under the spotlight by the U.S. Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee, which is ...
Read Full Story »
FDA_logo

5 Key FDA Decisions Expected in March

Companies in the pharmaceutical industry are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, ...
Read Full Story »
automatic inspection machine

6 Biotech and Pharma Stocks Analysts Want You to Buy Now

The end of 2015 and the start of 2016 have been hard on biotech, and in some cases have been hard for Big Pharma. It turns out that there is ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Tableau and Many More

Stocks were getting pounded on Monday after a rough Friday, on the continuation of oil and a weak Europe, even as China was closed for Chinese New Year. The stock ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: Amazon, Monsanto, Schlumberger, SolarCity, Western Digital, Yelp, Abercrombie and Many More

Stocks bounced big on Wednesday, but unlike Tuesday, the rally held and gained strength throughout the day. Stocks were green on Thursday morning too. This trend of buying the pullbacks, ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, Coach, Etsy, Intel, MannKind, Netflix, SanDisk, Starbucks and More

Stocks were down across the board on Thursday morning. Still all-time highs are not far off and investors have bought stocks on weakness for over three years now. 24/7 Wall ...
Read Full Story »
Biotechnology word cloud

Portfolio Managers Love These 5 Biotech Stocks

If there is one industry that had a busy January, it was biotech. In fact, January set an all-time record for issuance and funds raised in the biotech sector, and ...
Read Full Story »
biotech

The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher

Over the years biotech investors who have owned the right stocks have made some very big money on Federal Drug Administration (FDA) approval of leading drug candidates. Typically biotech firms ...
Read Full Story »
Bull and Bear figures

Closing Bell for Monday on Wall Street: Markets Open Higher, but Slip Later

U.S. equity markets opened higher this morning following some mixed economic data released in China. The country’s CPI rose less than expected, producer prices fell, fixed asset investment rose a ...
Read Full Story »
stock symbol ticker

Market Close: Big Winners & Losers for April 11, 2013 (ACAD, RAD, MEA, RDHL, INOC, NTIC, LEDS, DRTX, FTNT, GNVC)

Here are today’s five biggest gaining stocks at closing: ACADIA Pharmaceuticals inc. (NASDAQ: ACAD) is up 64.4% at $13.10. Rite Aid Corp. (NYSE: RAD) is up 18.4% at $2.12. Metalico ...
Read Full Story »